𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Transforming growth factor-β signaling in tumor initiation, progression and therapy in breast cancer: an update

✍ Scribed by Xuyu Zu; Qinghai Zhang; Renxian Cao; Jianghua Liu; Jing Zhong; Gebo Wen; Deliang Cao


Publisher
Springer-Verlag
Year
2011
Tongue
English
Weight
468 KB
Volume
347
Category
Article
ISSN
0302-766X

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Transforming growth factor-β signaling i
✍ Suvi-Katri Leivonen; Veli-Matti Kähäri 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 229 KB

## Abstract Transforming growth factor‐β (TGF‐β) family members are polypeptides with dual tumor suppressive and oncogenic effects. They signal through serine/threonine kinase receptor complexes, which phosphorylate cytoplasmic mediators, the Smads. Upon phosphorylation, Smads translocate to the nu

Disrupted transforming growth factor-β s
✍ Shujiro Yazumi; Kohaku Ko; Norihiko Watanabe; Hisashi Shinohara; Kiyotsugu Yoshi 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 714 KB

Biliary tract carcinoma is a common neoplasm in Japan, and its treatment is difficult because it tends to promote fibrosis and easily invades surrounding tissues. To better characterize the biological features of this carcinoma, we investigated abnormalities in the transforming growth factor-␤ (TGF-

Angiogenesis in breast cancer: The role
✍ Chenggang Li; Baoqiang Guo; Carmelo Bernabeu; Shant Kumar 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 486 KB 👁 1 views

The progression of breast cancer depends on the establishment of a neovasculature, by a process called angiogenesis. Angiogenesis is an invasive cellular event that requires the co-ordination of numerous molecules including growth factors and their receptors, extracellular proteins, adhesion molecul

Study of tumor infiltrating lymphocytes
✍ Aizen J. Marrogi; Anupama Munshi; Athir J. Merogi; Yvonne Ohadike; Ahmed El-Haba 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 974 KB

Cytokines and growth factors are powerful modulators of the immune response. Their aberrant expression either by the tumor cells or by the tumor infiltrating lymphocytes confers a selective advantage to the tumor to grow and suppress the cytotoxic activity of the infiltrating lymphocytes. Therefore,